| Prev Close | 207.48 |
| Open | 208.15 |
| Day Low/High | 207.90 / 210.42 |
| 52 Wk Low/High | 150.37 / 236.62 |
| Volume | 1.52M |
Constellation Brands, Inc. Class A (STZ)
210.14
2.66
1.28
NYSE
| Exchange | NYSE |
| Shares Outstanding | 189.88B |
| Market Cap | 39.01B |
| Div & Yield | N.A. (N.A) |
Chart of the Day: Constellation's Canopy Growth Engine
Canopy Growth could be Constellation's next big growth engine.
Constellation Shares Soar on Thursday
Shareholders enjoyed a crisp day of gains after Constellation cracked open a great earnings report pre-market.
Constellation Shareholders Cautious About the Company's Big Debt Burden
Investors and experts need more time before they go all in on cannabis.
Analysts, Traders Bullish on Constellation as it Shatters Earnings Estimates
Market experts are abuzz over Constellation's potential new inroads into the cannabis market.
Down the Marijuana Rabbit Hole: 5 Companies to Consider
It's too easy to lump all cannabis-related stocks into the moniker "marijuana." Like many other sectors, there are differentiators underneath the same way we see in semiconductors or retail or even energy. As you go down the marijuana rabbit hole, ...
Constellation Brands Is a Bright Star on a Down Day
With STZ's earnings beat and the potential of the CGC investment, investors are willing to pay a premium.
Want to Buy Constellation Brands Stock Today? Read On
I have no problem blessing an investment in this name with the appropriate steps taken toward risk management.
Constellation Brands Surges Higher, Start of a New Uptrend
A strong upside gap this morning really changes the picture.
Constellation Brands Buzzes on Raised Guidance, Growth Engines
Constellation looks to wine, beer, and cannabis to take it higher.
7 Smart Ways to Invest in Cannabis Stocks and Not Get Burned
There are several avenues to invest in the potential cannabis boom -- recreational plays; medical plays; and companies that have a lot to gain from the industry but aren't reliant upon it for success.
Two Cheers for Corona and Cannabis: Constellation Jumps on Earnings
Constellation looks like a star today after beating expectations.
2 Plays on JP Morgan to Boost Bank Exposure: Market Recon
Try these trades in JPM and Key to take advantage of weakness in the sector.
Cannabis Shorts: Is There Enough Liquidity?
Before you short cannabis names, read this.
Cannabis Could Disrupt the Lucrative Market for Painkillers
Painkiller manufacturers might see their profits hurt by medical cannabis in the near future.
Canopy Growth CEO: Traditional Firms Will See They Must Get Into Legal Cannabis
The only other option is 'to fearfully wait' for the legal-weed industry to expand.
Despite Taking Some Weed, Constellation Brands Charts Are Still Bearish
It is entirely possible that a business relationship with Canopy Growth will help Constellation Brands, but the charts currently suggest further risk for the beverage company.
Jim Cramer: Reefer Madness
Tilray's a disruptive company for many industries.
If You Must Trade Tilray, Use This Options Play: Market Recon
Covered calls may be the best bet -- or wait for a dip.
How to Play Tilray With Options
A so-called 'ratio-put spread' looks good here.
Play Tilray Using a 'Ratio-Put Spread'
This options trade combines some upside with a chance to buy TLRY at a decent price.
Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers
The cannabis company has gained DEA approval to import a cannabinoid drug into the U.S.
Experts Are High on Cannabis Stocks' 2019 Prospects
Expect more companies to join Coca-Cola, Molson Coors and Constellation Brands in checking out the market.
Aurora Cannabis Shares Surge as Coca-Cola Confirms CBD Interest
A tie-up between the two could mark the first major U.S. firm to establish a line of CBD drinks.
Coke's Flirtation with Cannabis Reaffirms What We Already Know
The latest reports about Coke looking into cannabis confirms a broader industry trend.
Jim Cramer: Be Cautious Before You Invest in the Budding Cannabis Industry
You don't want your money to go up in smoke.
3 Big-Name Stocks to Consider Shorting
A brewer facing challenges, a banking giant and a retail behemoth are ripe for downside plays.
Cannabis for Traders, Cannabis for Investors: Market Recon
Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.
Mainstream Research Just Doesn't Get Canopy Growth
Moody's and Zacks aren't seeing the potential for CBD drinks or even THC drinks.
